Valuation Jilin Aodong Pharmaceutical Group Co., Ltd.

Stocks

End-of-day quote Shenzhen S.E. 2026-10-29			5-day change	1st Jan Change
16.39 ^CNY	-1.97%		-3.70%	-16.08%

07:22am	Jilin Aodong Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2026	CI
10-15	Jilin Aodong Pharmaceutical Group Co., Ltd. Announces Interim Profit Distribution Plan for 2026 to Be Implemented (A Shares), payable on October 23, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025
Market Cap ¹	18,957	21,034	17,020	17,098	20,653	22,897
Change	-	10.96%	-19.09%	0.46%	20.79%	10.86%
Enterprise Value (EV) ¹	16,926	19,015	16,144	16,752	20,267	22,173
Change	-	12.34%	-15.1%	3.77%	20.98%	9.4%
P/E	11.5x	12.2x	10.2x	12.3x	13.1x	9.57x
PBR	0.81x	0.85x	0.65x	0.62x	0.7x	0.75x
PEG	-	2.14x	-3.47x	-0.8x	1.77x	0.2x
Capitalization / Revenue	8.42x	9.13x	5.93x	4.96x	7.91x	9.81x
EV / Revenue	7.52x	8.25x	5.63x	4.86x	7.76x	9.49x
EV / EBITDA	132x	95.6x	49.6x	49.5x	446x	855x
EV / EBIT	-257x	3,240x	124x	125x	-126x	-134x
EV / FCF	1,323x	-137x	-5,674x	-31.8x	-79.5x	155x
FCF Yield	0.08%	-0.73%	-0.02%	-3.14%	-1.26%	0.64%
Dividend per Share ²	0.2	0.3	0.3	0.6	0.5	0.5
Rate of return	1.21%	1.62%	2%	3.96%	2.9%	2.56%
EPS ²	1.43	1.511	1.467	1.227	1.318	2.042
Distribution rate	14%	19.9%	20.5%	48.9%	37.9%	24.5%
Net sales ¹	2,252	2,304	2,868	3,449	2,611	2,335
EBITDA ¹	128.5	199	325.3	338.7	45.48	25.92
EBIT ¹	-65.74	5.868	129.9	134.5	-160.4	-165.1
Net income ¹	1,709	1,781	1,781	1,460	1,551	2,395
Net Debt ¹	-2,031	-2,020	-875.8	-346	-386	-724
Reference price ²	16.47	18.47	14.99	15.14	17.27	19.53
Nbr of stocks (in thousands)	1,151,001	1,138,825	1,135,395	1,129,349	1,195,895	1,172,382
Announcement Date	4/16/21	4/15/22	4/18/23	4/16/24	4/22/25	4/17/26

¹CNY in Million²CNY

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
JILIN AODONG PHARMACEUTICAL GROUP CO., LTD.	-	-	-	-	2.94B
ELI LILLY AND COMPANY	37.84x	13.27x	28.43x	0.53%	1,148B
JOHNSON & JOHNSON	39.67x	6.67x	18.75x	1.97%	652B
ABBVIE INC.	37.4x	8.39x	17.35x	2.4%	505B
ROCHE HOLDING AG	21.45x	5.21x	12.93x	2.51%	384B
MERCK & CO., INC.	102.73x	5.76x	24.72x	2.42%	348B
NOVARTIS AG	21.89x	5.76x	13.88x	2.85%	294B
ASTRAZENECA PLC	22.21x	4.49x	12.82x	1.97%	264B
AMGEN INC.	28.66x	7.33x	13.12x	2.23%	244B
GILEAD SCIENCES, INC.	-45.79x	7.11x	27.55x	2.07%	197B
Average	29.56x	7.11x	18.84x	2.11%	404.01B
Weighted average by Cap.	35.29x	8.40x	20.64x	1.79%